Zusammenfassung
Für die Lungengerüsterkrankungen gibt es, verglichen mit den häufigeren obstruktiven Bronchopneumopathien wenig Gesichertes in der Therapie. Mit Ausnahme der Verabreichung von Kortikosteroiden sind essentielle kurative Möglichkeiten immer noch unsicher. Diese Sachlage erfordert um so intensivere Überlegungen zur Ätiopathogenese, damit die Heilungschancen durch Beseitigung exogenätiologischer oder endogenpathogenetischer Kausalfaktoren voll genutzt werden. Hierdurch wird auch der Weg zu einer begründeten Prophylaxe gezeigt. Schließlich bietet sich zur Problemlösung noch die therapeutische Beeinflussung sekundärer und komplikativer Krankheitserscheinungen an.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Carrington CB, Gaensler EA, Coutu RE, Fitzgerald MX, Gupla RG (1978) Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 298: 801
Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA (1984) Interstitital lung disease of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310: 154
Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA (1984) Interstitital lung disease of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 310: 235
Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW (1981) Interstitial lung disease: Current concepts of pathogenesis, staging and therapy. Am J Med 70: 542
Dayton CS, Schwartz DA, Helmers RA, Pueringer RJ, Gilbert SR, Merchant RK, Hunninghake GW (1993) Outcome of subjects with idiopathic pulmonary fibrosis who fail corticosteroid therapy. Chest 103: 69
Davis PB (1991) Cystic fibrosis from bench to bedside. N Engl J Med 325: 575
De Paso WJ (1991) Aspiration pneumonia. Clin Chest Med 12: 269
Egan TM, Westerman JH, Lambert CJ, Detterbeck FC, Thompson JT, Mill MR, Keagy BA, Paradowski LJ, Wilcox BR (1992). Isolated lung transplantation for end-stage lung disease: a viable therapy. Ann Thorac Surg 53: 590
Eliasson O, Cole SR, Degraff Jr AC (1985) Adverse effects of cyclophosphamide in idiopathic pulmonary fibrosis. Connect Med 49: 286
Eliasson AH, Phillips YY, Tenholder MF (1989) Treatment of Lymphangioleiomyomatosis. A Meta-analysis. Chest 196: 1352
Goodman GB, Kaplan PD, Stachura I, Castranova V, Pailes WH, Lapp NL (1992) Acute silicosis responding to corticosteroid therapy. Chest 101: 366
Gruhn WB, Diaz-Buxo JA (1987) Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 14: 1045
Hein R, Behr J, Hündgen M, Hunzelmann N, Meurer M, Braun-Falco O, Urbanski A, Krieg T (1992) Treatment of systemic sclerosis with γ-interferon. Br J Dermatol 126: 496
Hertier F, Madden B, Hodson ME, Yacoub M (1992) Lung allograft transplantation: indications, preoperative assessment and postoperative management. Eur Respir 5: 1262
Höper MM, Wagner TOF, van der Hardt H, Haverich A (1989) Indikation zur Transplantation der Lunge. Dtsch Med Wochenschr 114: 1927
Jackson RM (1990) Molecular, pharmacologic, and clinical aspects of oxygen-induced lung injury. Clin Chest Med 11: 73
Johnson MA, Kwan S, Snell NJC, Nunn AJ, Darbyshire JH, Turner-Warwick M (1989) Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic alveolitis. Thorax 44: 280
Kaye MP (1992) The registry of the international society for heart and lung transplantation ninth official report — 1992. J Heart Lung Transpl 11: 599
Keogh BA, Bernardo J, Hunninghake GW, Line BR, Price DL, Crystal RG (1983) Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis. Am Rev Respir Dis 127: 18
König G, Luderschmidt C, Hammer C, Adelmann-Grill BC, Braun-Falco O, Fruhmann G (1984) Lung involvement in scleroderma. Chest 85: 318
Krause-Michel B, Bachhuber W, Baldauf H, Dirmeier J, Nolte D (1990) Sauerstoff-Langzeit-Therapie. Atemw Lun-genkrankh 16: 31
Krieg T, Meurer M (1988) Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol 18: 457
Leavitt RY, Fauci AS (1986) Pulmonary vasculitis. Am Rev Respir Dis 134: 149
Macnaughton PD, Evans TW (1992) Management of adult respiratory distress syndrome. Lancet 339: 469
Manolis AS, Tordjman T, Mack KD, Mark-Estes III NA (1987) Atypical pulmonary and neurologic complications of Amiodarone in the same patient. Report of a case and review of the literature. Arch Intern Med 147: 1805
Mayer E, Jakob HG, Hake U, Dahm M, Patterson GA, Oelert H (1992) Isolierte Lungentransplantation. I. Indikationen und Auswahlkriterien. Pneumology 46: 505
Müller-Wening D, Repp H (1989) Investigation on the protective value of breathing masks in farmer’s lung using an inhalation provocation test: Chest 95: 100
Obrist R, Obrecht JP (1978) Die Zytostatika-Pneumopathie. Dtsch Med Wochenschr 103: 765
O’Donnell K, Keogh B, Cantin A, Crystal RG (1987) Pharmacologic suppression of the neutrophil component of the alveolitis in idiopathic pulmonary fibrosis. Am Rev Respir Dis 136: 288
Otto H (1975) Zur Morphologie des Endbildes und der behandlungsbedürftigen Frühphasen interstitieller Lungenfibrosen. In: Hamm J (Hrsg) Interstitielle Lungenerkrankungen — Lungen-Fibrosen. Thieme, Stuttgart, S1
Patterson GA, Maurer JR, Williams TJ, Cardoso PG, Scavuzzo M, Todd TR (1991). Comparison of outcomes of double and single lung transplantation for obstructive lung disease. J Thorac Cardiovasc Surg 101: 623
Peters SG, McDougall JC, Douglas WW, Coles DT, DeRemee RA (1993) Colchicine in the treatment of pulmonary fibrosis. Chest 103: 101
Rosenow III EC, Myers JL, Swensen SJ, Pisani RJ (1992) Drug-induced pulmonary disease. An Update. Chest 102: 239
Rudd RM, Haslam PL, Turner-Warwick M (1981) Cryptogenic fibrosing alveolitis. Relationship of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Resp Dis 124: 1
Scott DGI, Bacon PA (1980) Response to methotrexate in fibrosing alveolitis associated with connective tissue disease. Thorax 35: 725
Strausz J, Müller-Quernheim J, Steppling H, Ferlinz R (1990) Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am Rev Respir Dis 141: 124
Taylor JR, Ryu J, Colby TV, Raffin TA (1990) Lymphangio-leiomoyomatosis. Clinical course in 32 patients. N Engl J Med 323: 1254
Turner-Warwick M, Burrows B, Johnson A (1980) Cryptogenic fibrosing alveolitis: to corticosteroid treatment and its effect on survival. Thorax 35: 593
Winterbauer RH (1991) The treatment of idiopathic pulmonary fibrosis. Chest 100: 233
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fruhmann, G., Vogelmeier, C. (1995). Lungengerüsterkrankungen. In: Paumgartner, G., Riecker, G. (eds) Therapie innerer Krankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-10479-8_22
Download citation
DOI: https://doi.org/10.1007/978-3-662-10479-8_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-10480-4
Online ISBN: 978-3-662-10479-8
eBook Packages: Springer Book Archive